News – Page 978 – Endpoints News

Clive Meanwell gives way to new CEO as activist investor Alex Denner shakes up The Medicines Company

7 years ago

Freshman lawmakers give J&J CEO Alex Gorsky another unwanted turn in the public spotlight

7 years ago

Black Diamond turns down an open stretch of R&D highway, headed to a showdown with oncogenes

7 years ago

Targeting CD47? UCLA joins bandwagon, with gel to stem tumors from resurfacing

7 years ago

Too much success? A booming biotech pipeline will spur intense rivalries — analyst

7 years ago

Sue Dillon, Karyn O'Neil steer fledgling Aro Biotherapeutics to $13M debut — with J&J's blessing

7 years ago

Shanghai Junshi Biosciences next to test HKEX listing; With one eye on Sage, Marinus reports prelim PPD data

7 years ago

WuXi AppTec starts a global wave of expansion, jumping off in San Diego following $1B Hong Kong IPO raise

7 years ago

Nasdaq celebrates epic biotech IPO success in 2018. But can the party on Wall Street rumba on?

7 years ago

AstraZeneca, Cancer Research UK set up genomics hub to fight uphill battle against cancer

7 years ago

0-for-2: Another faded drug star in Axovant's much-hyped pipeline falls, tarnishing Ramaswamy's deal-making rep

7 years ago

FDA slaps partial hold on MacroGenics for bispecific cancer trials as liver tox spurs safety fears

7 years ago

Gilead locks in Daniel O'Day as CEO, tapping the Roche vet to rejuvenate growth

7 years ago

With fresh company building lessons from Ablynx, Edwin Moses is ready to try it again as chair of neoantigen biotech ...

7 years ago

Sanofi will eliminate 670 jobs in France; Moderna gets FDA orphan status for preclinical asset

7 years ago

Delay brings success for Roche as it finally wins FDA nod for Tecentriq regimen in frontline lung cancer

7 years ago

Bristol-Myers vet Caroline Loew heads up Glympse Bio; Kaleido nabs GSK's CMO Katharine Knobil

7 years ago

FDA will allow observational studies as part of a push for real world evidence, new framework says

7 years ago

Accused of milking the CMS with co-pay kickbacks, J&J's Actelion settles case for $310M

7 years ago

AstraZeneca's prized Imfinzi/tremelimumab combo fails again — this time in head and neck cancer

7 years ago

Moderna skirts the reefs of disaster and sails into Wall Street with a $604M IPO bounty — but shares slide

7 years ago

Mallinckrodt to spin off generics business; BeyondSpring ready to submit approval for lead drug in China

7 years ago

Joining hunt for hep B cure, Brii Bio inks maiden deals featuring VBI, Vir, WuXi with a big appetite for more

7 years ago

In search of biotech hub glory, the Big Apple lures local startups with lab space

7 years ago

First page Previous page 975 976 977978979 980 981 Next page Last page